Screening Test Standards. The lab shall use an immunoassay which meets the requirements of the food and drug administration for commercial distribution. The following initial immunoassay test cutoff levels shall be used when screening urine specimens to determine whether they are negative for the eight (8) drugs or classes of drugs: Initial Test Level Marijuana metabolites 50ng/mL Cocaine metabolites 300ng/mL Opiate metabolites* 2000ng/mL Phencyclidine 25ng/mL Amphetamines 1000ng/mL Methaqualone 200ng/mL Benzodiazepines 300ng/mL Barbiturates 200ng/mL Oxycontin 100ng/mL Ecstasy 500ng/mL *If immunoassay is specific for free morphine, the initial testing level is 25ng/mL (these numbers may be revised by the city to remain consistent with HHS guidelines.) Confirmatory test standards. All urine specimens identified as positive on the initial screening test shall be confirmed using GC/MS techniques at the cutoff levels listed below. All confirmations shall be by quantitative analysis. Confirmatory Test Levels Marijuana metabolites* 15ng/mL Cocaine metabolites** 150ng/mL Opiates: morphine 2000ng/mL Codeine 300ng/mL Phencyclidine 25ng/mL Amphetamines: amphetamine 500ng/mL Methamphetamine 500ng/mL Methaqualone 200ng/mL Benzodiazepines 300ng/mL Barbiturates 200ng/mL Oxycontin 50ng/mL Ecstasy 300ng/mL * Delta 9 Tetrahydrocannabinol 9 Carboxylic Acid **Benzoyl ecgonine (These numbers may be revised by the city to remain consistent with HHS guidelines.) Testing for other prescription drugs. Any tests for prescription drugs not listed above shall use the screening test cut-off levels and the confirmatory GC/MS test cut-off levels for such drugs established by the testing laboratory selected by the city in accordance with the standards established by this contract or HHS standards, if any.
Appears in 2 contracts
Samples: dam.assets.ohio.gov, Collective Bargaining Agreement
Screening Test Standards. The lab shall use an immunoassay which meets the requirements of the food and drug administration for commercial distribution. The following initial immunoassay test cutoff levels shall be used when screening urine specimens to determine whether they are negative for the eight (8) drugs or classes of drugs: Initial Test Level Marijuana metabolites 50ng/mL Cocaine metabolites 300ng300 150ng/mL Opiate metabolites* 2000ng/mL Phencyclidine 25ng/mL Amphetamines 1000ng1000 500ng/mL Methaqualone 200ng/mL Benzodiazepines 300ng/mL Barbiturates 200ng/mL Oxycontin 100ng/mL Ecstasy 500ng/mL *If immunoassay is specific for free morphine, the initial testing level is 25ng/mL (these numbers may be revised by the city to remain consistent with HHS guidelines.) Confirmatory test standards. All urine specimens identified as positive on the initial screening test shall be confirmed using GC/MS techniques at the cutoff levels listed below. All confirmations shall be by quantitative analysis. Confirmatory Test Levels Marijuana metabolites* 15ng/mL Cocaine metabolites** 150ng150 100ng/mL Opiates: morphine 2000ng/mL Codeine 300ng300 2000ng/mL Phencyclidine 25ng/mL Amphetamines: amphetamine 500ng500 250ng/mL Methamphetamine 500ng500 250ng/mL Methaqualone 200ng/mL Benzodiazepines 300ng/mL Barbiturates 200ng/mL Oxycontin 50ng50 100ng/mL Ecstasy 300ng300 250ng/mL * Delta 9 Tetrahydrocannabinol 9 Carboxylic Acid **Benzoyl ecgonine (These numbers may be revised by the city to remain consistent with HHS guidelines.) Testing for other prescription drugs. Any tests for prescription drugs not listed above shall use the screening test cut-off levels and the confirmatory GC/MS test cut-off levels for such drugs established by the testing laboratory selected by the city in accordance with the standards established by this contract or HHS standards, if any.
Appears in 2 contracts
Samples: Collective Bargaining Agreement, serb.ohio.gov
Screening Test Standards. The lab shall use an immunoassay which meets the requirements of the food and drug administration for commercial distribution. The following initial immunoassay test cutoff levels shall be used when screening urine specimens to determine whether they are negative for the eight (8) drugs or classes of drugs: Initial Test Level Marijuana metabolites 50ng/mL Cocaine metabolites 300ng/mL Opiate metabolites* 2000ng/mL Phencyclidine 25ng/mL Amphetamines 1000ngXxxxxxxxxxxx 0000xx/mL Methaqualone xX Xxxxxxxxxxxx 200ng/mL Benzodiazepines 300ng/mL Barbiturates 200ng/mL Oxycontin 100ng/mL Ecstasy 500ng/mL *If immunoassay is specific for free morphine, the initial testing level is 25ng/mL (these numbers may be revised by the city to remain consistent with HHS guidelines.) Confirmatory test standards. All urine specimens identified as positive on the initial screening test shall be confirmed using GC/MS techniques at the cutoff levels listed below. All confirmations shall be by quantitative analysis. Confirmatory Test Levels Marijuana metabolites* 15ng/mL Cocaine metabolites** 150ng/mL Opiates: morphine 2000ng/mL Codeine 300ng/mL Phencyclidine 25ng/mL Amphetamines: amphetamine 500ng/mL Methamphetamine 500ng/mL Methaqualone 200ng/mL Benzodiazepines 300ng/mL Barbiturates 200ng/mL Oxycontin 50ng/mL Ecstasy 300ng/mL * Delta 9 Tetrahydrocannabinol 9 Carboxylic Acid **Benzoyl ecgonine (These numbers may be revised by the city to remain consistent with HHS guidelines.) Testing for other prescription drugs. Any tests for prescription drugs not listed above shall use the screening test cut-off levels and the confirmatory GC/MS test cut-off levels for such drugs established by the testing laboratory selected by the city in accordance with the standards established by this contract or HHS standards, if any.
Appears in 1 contract
Samples: serb.ohio.gov